Nitipong Permpalung1, Navaporn Worasilchai2, Rongpong Plongla3, Sikarin Upala4, Anawin Sanguankeo4, Leilani Paitoonpong3, Leonel Mendoza5, Ariya Chindamporn6. 1. Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Department of Medicine, Bassett Medical Center and Columbia University College of Physicians and Surgeons, Cooperstown, NY, USA. 2. Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. 3. Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand. 4. Department of Medicine, Bassett Medical Center and Columbia University College of Physicians and Surgeons, Cooperstown, NY, USA Department of Preventive and Social Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand. 5. Microbiology and Molecular Genetics, Biomedical Laboratory Diagnostics, Michigan State University, East Lansing, MI, USA. 6. Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand cariya@chula.ac.th.
Abstract
OBJECTIVES: Human pythiosis is a life-threatening disease for which no standard treatment protocols with proven efficacy exist. We present the results of our institutional pythiosis treatment protocol, composed of surgery, antifungal agents, iron chelator (only vascular cases) and immunotherapy. METHODS: We retrospectively analysed patients with proven vascular and ocular pythiosis in King Chulalongkorn Memorial Hospital from April 2003 to May 2013. Fisher's exact test and Wilcoxon's rank-sum test were used. The MICs of seven antifungal agents and combination drugs were investigated in eight clinical Pythium insidiosum strains. RESULTS: Eighteen patients were evaluated. Disease-free surgical margins were obtained in all surviving patients with vascular pythiosis (P = 0.08). Patients who underwent eye enucleation were significantly older than those who did not (P < 0.05). Patients with vascular or ocular pythiosis did not differ significantly in the median time from disease onset to first surgery or in the relationship between the type of P. insidiosum antigen and treatment outcomes. In vitro susceptibility profiles of all isolates demonstrated that no single agent or combination treatment was substantially more effective than the others. The highest MIC was detected for amphotericin B, followed in order by voriconazole, fluconazole, anidulafungin, caspofungin, itraconazole and terbinafine. No synergistic effects of the combination drug treatments were found. CONCLUSIONS: Surgery with adequate surgical margins is a crucial determinant of survival in patients with vascular pythiosis. Itraconazole and terbinafine do not have synergistic effects on Thai P. insidiosum strains. The role of immunotherapy remains inconclusive for both vascular and ocular pythiosis.
OBJECTIVES:Human pythiosis is a life-threatening disease for which no standard treatment protocols with proven efficacy exist. We present the results of our institutional pythiosis treatment protocol, composed of surgery, antifungal agents, iron chelator (only vascular cases) and immunotherapy. METHODS: We retrospectively analysed patients with proven vascular and ocular pythiosis in King Chulalongkorn Memorial Hospital from April 2003 to May 2013. Fisher's exact test and Wilcoxon's rank-sum test were used. The MICs of seven antifungal agents and combination drugs were investigated in eight clinical Pythium insidiosum strains. RESULTS: Eighteen patients were evaluated. Disease-free surgical margins were obtained in all surviving patients with vascular pythiosis (P = 0.08). Patients who underwent eye enucleation were significantly older than those who did not (P < 0.05). Patients with vascular or ocular pythiosis did not differ significantly in the median time from disease onset to first surgery or in the relationship between the type of P. insidiosum antigen and treatment outcomes. In vitro susceptibility profiles of all isolates demonstrated that no single agent or combination treatment was substantially more effective than the others. The highest MIC was detected for amphotericin B, followed in order by voriconazole, fluconazole, anidulafungin, caspofungin, itraconazole and terbinafine. No synergistic effects of the combination drug treatments were found. CONCLUSIONS: Surgery with adequate surgical margins is a crucial determinant of survival in patients with vascular pythiosis. Itraconazole and terbinafine do not have synergistic effects on Thai P. insidiosum strains. The role of immunotherapy remains inconclusive for both vascular and ocular pythiosis.
Authors: Francielli P K Jesus; Érico S Loreto; Laerte Ferreiro; Sydney H Alves; David Driemeier; Suyene O Souza; Raqueli T França; Sonia T A Lopes; Maiara B Pilotto; Aline Ludwig; Maria I Azevedo; Tatiana C Ribeiro; Juliana S M Tondolo; Janio M Santurio Journal: Antimicrob Agents Chemother Date: 2015-10-12 Impact factor: 5.191
Authors: Erico S Loreto; Juliana S M Tondolo; Francielli P K de Jesus; Camila M Verdi; Carla Weiblen; Maria I de Azevedo; Glaucia D Kommers; Janio M Santurio; Régis A Zanette; Sydney H Alves Journal: Antimicrob Agents Chemother Date: 2018-12-21 Impact factor: 5.191
Authors: Juliana S M Tondolo; Érico S Loreto; Pauline C Ledur; Francielli P K Jesus; Taiara M Silva; Glaucia D Kommers; Sydney H Alves; Janio M Santurio Journal: PLoS One Date: 2017-05-19 Impact factor: 3.240
Authors: Tatiana Maria Inêz-Ferreira; Leonel Mendoza; Raquel Vilela; Hélida Monteiro de Andrade; João Paulo Haddad; Fernanda Freire Campos Nunes; Isabela Moreira Gondim; Tânia Mara Pinto Dabés Guimarães; Vicente de Paulo Coelho Peixoto de Toledo Journal: Heliyon Date: 2017-03-30